La rifampicine dans le traitement de la tuberculose pulmonaire active. Essai controle isoniazide-rifampicine-thiocarlide versus isoniazide-streptomycine-thiocarlide dans les tuberculoses non traitees. Traitement des rechutes par l'association rifampicine-ethambutol-thiocarlide. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide]
Details
Serval ID
serval:BIB_FDC3271562CD
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
La rifampicine dans le traitement de la tuberculose pulmonaire active. Essai controle isoniazide-rifampicine-thiocarlide versus isoniazide-streptomycine-thiocarlide dans les tuberculoses non traitees. Traitement des rechutes par l'association rifampicine-ethambutol-thiocarlide. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide]
Journal
Schweizerische Medizinische Wochenschrift
ISSN
0036-7672 (Print)
Publication state
Published
Issued date
03/1974
Volume
104
Number
10
Pages
356-64
Notes
Clinical Trial
Comparative Study
Controlled Clinical Trial
Journal Article
Randomized Controlled Trial --- Old month value: Mar 9
Comparative Study
Controlled Clinical Trial
Journal Article
Randomized Controlled Trial --- Old month value: Mar 9
Keywords
Clinical Trials
Drug Hypersensitivity
Drug Therapy, Combination
Ethambutol/*therapeutic use
Gastrointestinal Diseases/chemically induced
Isoniazid/adverse effects/*therapeutic use
Liver Diseases/chemically induced
Mycobacterium tuberculosis/isolation & purification
Phenylthiourea/*analogs & derivatives/*therapeutic use
Pyridoxine/therapeutic use
Recurrence
Rifampin/adverse effects/*therapeutic use
Streptomycin/adverse effects/*therapeutic use
Thrombocytopenia/chemically induced
Time Factors
Tuberculosis, Pulmonary/*drug therapy/microbiology
Pubmed
Web of science
Create date
24/01/2008 17:52
Last modification date
20/08/2019 17:28